Vicore is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Buloxibutid (C21) is a first-in-class orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. Almee™ (an investigational medical device in clinical development) is a digital therapeutic based on cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis. Almee has received Breakthrough Device Designation from the FDA, reflecting its potential to have transformative impact. Using its unique expertise in ATRAG chemistry and biology, Vicore is further fueling its pipeline with several new therapies across additional potential indications. The company’s shares (VICO) are listed on Nasdaq Stockholm’s main market. For more information, see www.vicorepharma.com.


Clinical Trials

Medical Devices

Pharmaceutical

Vicore Pharma AB

Vicore Pharma AB's headquarters in Stockholm, Sweden

This department focuses on developing and optimizing analytical methods and processes to support product development and quality assurance.

Analytical Development

This department oversees the strategic direction and governance of the organization through its board members.

Board Governance

This department oversees the strategic direction and operational management of the organization through senior executive roles.

Executive Leadership

This department manages the clinical and scientific communication related to medical products and services.

Medical Affairs

This department oversees clinical development and regulatory affairs to ensure compliance and strategic advancement in medical research.

Clinical Operations

This department is responsible for managing and facilitating clinical science initiatives, including liaising between clinical functions and stakeholders.

Clinical Science

This department focuses on overseeing the development and management of chemistry, manufacturing, and controls processes in clinical research.

People (0)

Jobs (0)

Other teams

Board Governance

Executive Leadership

Medical Affairs

Clinical Operations

Clinical Science

CMC Operations